Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹3,737Cr
Rev Gr TTM
Revenue Growth TTM
-2.99%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

CHEMPLASTS
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -36.5 | -29.4 | -17.3 | -25.3 | -8.4 | 14.9 | 0.5 | 19.1 | 9.5 | -3.9 | 4.1 | -21.0 |
| 1,049 | 1,031 | 942 | 895 | 1,030 | 1,021 | 967 | 1,026 | 1,114 | 1,083 | 990 | 892 |
Operating Profit Operating ProfitCr |
| 8.5 | -3.5 | 4.7 | -0.7 | 2.0 | 10.8 | 2.6 | 3.0 | 3.2 | 1.6 | 4.2 | -6.8 |
Other Income Other IncomeCr | 31 | 18 | 37 | 13 | 13 | 12 | 11 | 11 | 14 | 9 | 7 | 5 |
Interest Expense Interest ExpenseCr | 38 | 44 | 39 | 47 | 51 | 59 | 57 | 59 | 62 | 59 | 60 | 58 |
Depreciation DepreciationCr | 33 | 32 | 35 | 38 | 46 | 45 | 45 | 47 | 62 | 53 | 52 | 53 |
| 56 | -93 | 9 | -78 | -63 | 32 | -65 | -63 | -73 | -86 | -62 | -163 |
| 10 | -29 | -17 | 11 | -32 | 8 | -34 | -14 | -19 | -22 | -11 | -44 |
|
Growth YoY PAT Growth YoY% | -80.1 | -257.6 | -32.4 | -429.3 | -167.6 | 137.3 | -220.0 | 45.4 | -74.0 | -368.9 | -63.3 | -144.2 |
| 4.0 | -6.4 | 2.6 | -10.1 | -3.0 | 2.1 | -3.1 | -4.6 | -4.7 | -5.8 | -4.9 | -14.3 |
| 2.9 | -4.0 | 1.6 | -5.7 | -2.0 | 1.5 | -1.9 | -3.1 | -3.4 | -4.0 | -3.2 | -7.5 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 0.3 | 202.1 | 55.1 | -16.1 | -20.6 | 10.8 | -5.2 |
| 933 | 945 | 2,837 | 4,695 | 4,473 | 3,902 | 4,127 | 4,079 |
Operating Profit Operating ProfitCr |
| 25.6 | 24.8 | 25.3 | 20.3 | 9.5 | 0.6 | 5.0 | 1.0 |
Other Income Other IncomeCr | -23 | -58 | 150 | 57 | -1 | 85 | 47 | 35 |
Interest Expense Interest ExpenseCr | 48 | 95 | 433 | 322 | 154 | 181 | 236 | 239 |
Depreciation DepreciationCr | 56 | 87 | 131 | 137 | 142 | 151 | 199 | 220 |
| 193 | 72 | 547 | 796 | 172 | -226 | -169 | -384 |
| 75 | 26 | 137 | 147 | 19 | -67 | -59 | -96 |
|
| | -61.1 | 789.1 | 58.2 | -76.5 | -204.0 | 30.3 | -161.6 |
| 9.4 | 3.7 | 10.8 | 11.0 | 3.1 | -4.0 | -2.5 | -7.0 |
| 4.5 | 2.0 | 30.6 | 43.7 | 9.6 | -10.0 | -6.9 | -18.1 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 67 | 67 | 67 | 79 | 79 | 79 | 79 | 79 |
| 1,795 | 1,845 | -451 | 1,592 | 1,745 | 1,587 | 1,955 | 1,874 |
Current Liabilities Current LiabilitiesCr | 692 | 428 | 1,998 | 2,256 | 2,234 | 2,484 | 2,715 | 2,797 |
Non Current Liabilities Non Current LiabilitiesCr | 610 | 1,767 | 2,838 | 1,642 | 1,744 | 1,846 | 1,720 | 1,724 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 1,535 | 443 | 1,275 | 2,261 | 2,146 | 1,841 | 1,775 | 1,640 |
Non Current Assets Non Current AssetsCr | 2,266 | 3,665 | 3,212 | 3,341 | 3,691 | 4,189 | 4,728 | 4,834 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 234 | 166 | 1,076 | 901 | 355 | -245 | 172 |
Investing Cash Flow Investing Cash FlowCr | 0 | -438 | 2,152 | 108 | -217 | -524 | -407 |
Financing Cash Flow Financing Cash FlowCr | 0 | 298 | -3,017 | -313 | -27 | 382 | 66 |
|
Free Cash Flow Free Cash FlowCr | 234 | 116 | 1,022 | 849 | -64 | -833 | -188 |
| 197.7 | 360.0 | 262.5 | 138.9 | 233.3 | 154.6 | -155.6 |
CFO To EBITDA CFO To EBITDA% | 73.0 | 53.2 | 112.0 | 75.3 | 75.9 | -1,142.9 | 78.5 |
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 10,506 | 5,486 | 7,056 | 6,892 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 16.2 | 36.0 | 0.0 | 0.0 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 | 1.8 | 1.1 | 1.8 | 1.6 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 147.0 | 20.4 | 45.4 | 62.3 |
| 0.4 | 3.7 | 1.4 | 8.5 | 11.3 | 364.1 | 36.6 |
Profitability Ratios Profitability Ratios |
| 68.1 | 66.5 | 44.1 | 37.0 | 35.0 | 31.0 | 36.7 |
| 25.6 | 24.8 | 25.3 | 20.3 | 9.5 | 0.6 | 5.0 |
| 9.4 | 3.7 | 10.8 | 11.0 | 3.1 | -4.0 | -2.5 |
| 11.8 | 5.3 | 59.1 | 43.8 | 11.4 | -1.4 | 1.7 |
| 6.4 | 2.4 | -106.8 | 38.8 | 8.3 | -9.5 | -5.4 |
| 3.1 | 1.1 | 9.1 | 11.6 | 2.6 | -2.6 | -1.7 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Chemplast Sanmar Limited (CSL) is a leading Indian specialty chemicals manufacturer with a dominant presence in high-value chemical segments, particularly **Specialty Paste PVC Resin**, **Custom Manufactured Chemicals (CMC)**, and **Value-Added Chemicals**. A subsidiary of the 60-year-old **Sanmar Group**, and backed by international investor **Fairfax**, CSL combines deep technological expertise, vertical integration, and strategic capacity expansion to strengthen its market leadership. The company operates four integrated manufacturing facilities across **Tamil Nadu and Puducherry**, serving over 25 Indian states and exporting to nine countries.
---
### **Core Business Segments**
#### **1. Specialty Paste PVC Resin**
- **Market Leadership**: CSL is the **largest manufacturer of specialty paste PVC resin in India**, commanding ~83% of domestic production capacity and ~66% market share.
- **Capacity Expansion**: Expanded capacity from 66 ktpa to **107,000 tonnes per annum (KTPA)** with the commissioning of a 41 ktpa brownfield facility at **Cuddalore** in FY24.
- **Application Areas**: Key end-uses include **leather cloth for footwear, automotive upholstery, mats, gloves, and coated fabrics**.
- **Import Substitution**: Over 50% of domestic demand is met through imports, presenting a large structural opportunity. No new domestic capacity has been announced due to high technological barriers and complex processes.
- **Technology Edge**: One of only two Indian companies with **proprietary micro-suspension technology**, which is **not licensed externally**, creating a durable competitive moat.
- **Backward Integration**: Internally produces **VCM and EDC**, covering over 60% of upstream needs, enhancing cost efficiency and supply chain security.
#### **2. Custom Manufactured Chemicals (CMC) Division**
- **Business Model**: Operates on a **“One Product to One Customer”** model, delivering **customized intermediates, starting materials, and active ingredients (AIs)** for **global innovator companies** in **agrochemicals, pharmaceuticals, and fine chemicals**.
- **Strategic Focus**: A high-margin business (targeting 23–25% EBITDA) and a **core priority for capital allocation**.
- **Growth Drivers**:
- Global **"China+1" sourcing strategy** increasing outsourcing to India.
- Strong regulatory and compliance reputation with **R&D and SHE (Safety, Health, Environmental) certifications**.
- Rising global demand for **eco-friendly, low-toxicity, and biodegradable agrochemicals**.
- **Key Chemistry Capabilities**: Expertise in **cyanation, hydrogenation, diazotization, liquid purification**, and handling **hazardous chemicals** (e.g., chlorine, fluorine, peroxides, sodium cyanide).
- **R&D and Scale-up**: Offers **end-to-end services**, from **process research to commercial manufacturing**, supported by in-house pilot plants and process engineering.
- **Performance**: Delivered over **80% YoY revenue growth in FY25**, surpassing **₹500 crores** in sales. Targeting **₹1,000 crores annual revenue** by FY27–28.
- **Letters of Intent (LoIs)**:
- Secured **6 LoIs** from global agrochemical innovators over the past two years, including **three for active ingredients (AIs)**.
- First contract to **manufacture a patented AI** signals a strategic shift into higher-value molecule production.
#### **3. Multi-Purpose Block (MPB) Expansion**
- **Phase 1**: Commissioned in **September 2023** at Berigai.
- **Phase 2**: Commissioned in **December 2024 (FY25)**.
- **Phase 3 & MPB-4**: Under development with civil and infrastructure work underway.
- **Total CAPEX**: Over **₹1,600 crores** committed to CMC and Paste PVC expansions.
- **Capacity**: Custom manufacturing capacity scaled from **1,068 mtpa to 4,500 mtpa**, enabling support for complex, high-margin molecules.
- **Utilization Outlook**: Strong pipeline supports **peak utilization within 2–3 years**; **₹1,000 crores+ revenue potential** from LoI pipeline.
#### **4. Suspension PVC (S-PVC) – Via Subsidiary CCVL**
- **Chemplast Cuddalore Vinyls Limited (CCVL)** is the **second-largest S-PVC producer in India** and the **market leader in South India** with **331 ktpa capacity** (expanded from 300 ktpa via debottlenecking).
- **Market Dynamics**:
- Domestic demand: ~**4.3–4.5 million mtpa**.
- ~60% of demand met through **imports**, creating major import substitution potential.
- Growth driven by **infrastructure, irrigation, window profiles, and furniture**.
- **Feedstock Advantage**: Leverages **captive marine terminal** for **VCM imports** (via undersea pipelines from Mitsubishi), ensuring reliable, cost-efficient supply.
- **Challenges**: Margin pressure due to **dumping of low-cost Chinese PVC** (~1.2 million tons imported in FY25), though **anti-dumping duties are expected soon**.
#### **5. Value-Added Chemicals**
- Integrated chlor-alkali platform producing:
- **Caustic Soda**: **119,000 mtpa**, ranking **4th in India** and **leading in South India**.
- **Hydrogen Peroxide**: **34,000 mtpa at 50% concentration**, **#1 producer in South India**.
- **Chloromethanes**: **35,000 mtpa**, used internally for **R-22 refrigerant gas**.
- **Joint Production**: All products co-produced during **chlorine manufacturing**, with **100% internal chlorine consumption**, eliminating disposal issues.
- **Sales Performance**: Record **109,479 mtpa caustic soda sold in FY25**, highest in 13 years.
- **Revenue Contribution**: ~25% of FY24 revenue.
---
### **Strategic Initiatives & Investments**
#### **Greenfield R-32 Refrigerant Gas Project**
- **Location**: Karaikal.
- **Investment**: ₹340 crores.
- **Product**: **R-32**, a **next-generation refrigerant** with **lower global warming potential (GWP)** than R-22.
- **Market Opportunity**: Driven by **rising air conditioning demand in tropical India** and **global shift toward sustainable refrigerants**.
- **Leverage**: Builds on existing **R-22 and chloromethane expertise**.
- **Export Potential**: Projected domestic demand to exceed **50,000 tons by 2030**, with surplus expected to be **exported**.
#### **Vertical Integration & Cost Efficiency**
- **Internal Feedstock Production**:
- **EDC, VCM, chlorine, hydrogen, caustic soda**.
- **Captive salt pans (Vedaranyam)** ensure reliable, low-cost salt supply.
- **Captive power plants** (coal and gas-based) reduce energy cost volatility.
- **Marine Terminals**: At **Cuddalore and Karaikal** for **importing ethylene and VCM**, enhancing logistics efficiency.
- **Closed-Loop Model**: Maximizes resource efficiency and reduces external dependencies.
#### **China+1 Beneficiary**
- Increasing global shift in **custom manufacturing** from China to India.
- India's advantages: **skilled workforce, R&D capabilities, IP security, and regulatory compliance**.
- CSL is a **preferred partner** for innovators seeking **non-China, HSE-compliant, and IP-protected** manufacturing.
---
### **Market Opportunities & Challenges**
#### **Opportunities**
- **Import Substitution**:
- **Paste PVC**: ~180 ktpa market; CSL accounts for 107 ktpa.
- **S-PVC**: ~4.3 million mtpa demand vs. ~1.7 million mtpa domestic production.
- **Growth in Outsourced Custom Manufacturing**:
- Indian share in global agro-CMC market growing at **10–12% annually**.
- Rising **API manufacturing penetration in India**.
- **Global Trends**:
- Demand for **personalized medicine**, **biologics**, and **eco-friendly agrochemicals**.
- **Food security, climate change, and sustainable farming** driving new molecule demand.
#### **Challenges**
- **Dumping of Chinese Chemicals**:
- Suspension PVC imports surged from 250,000 to **1.2 million mtpa**.
- Unfair pricing pressures margins; **anti-dumping duties anticipated**.
- **Commodity Price Volatility**: Especially in **VCM, EDC, and energy inputs**.
- **Limited Presence in East & Northeast India**: Focus remains on South and East.
---
### **Financials & Operational Highlights (FY24–FY25)**
- **Consolidated Revenue (FY24)**: ₹3,923 crores.
- **EBITDA (FY24)**: ₹26 crores (affected by margin pressures; higher in Specialty segments).
- **Sales Mix (FY24)**:
- Suspension PVC: **62%**
- Chloromethanes: **25%**
- Specialty Chemicals: **13%**
- **Profitability Profile**:
- Specialty chemicals contribute **disproportionately to EBITDA** (>50% in FY23 despite ~17–22% of sales).
- Expected to become **largest profit driver** post-capacity ramp-up.
- **Balance Sheet**: **Debt-free on standalone basis**; strong cash position.
---
### **Strategic Differentiators**
| **Factor** | **Competitive Advantage** |
|----------|--------------------------|
| **Technology** | Proprietary Paste PVC and advanced chemistry processes |
| **Integration** | Fully backward-integrated across VCM, EDC, chlorine, salt, power |
| **Location** | Coastal plants with marine terminals for efficient logistics |
| **Compliance** | SHE audits passed; Responsible Care certified; zero liquid discharge |
| **Customer Stickiness** | Long-term partnerships (>15 years), early engagement in product lifecycle |
| **R&D Capability** | 75+ chemists/engineers; modular pilot plants; scale-up expertise |